Home > Press > SWR&D Issued Patent for Nano-Scaled Constructs
Abstract:
Lawton-based SWR&D, Inc. has been issued a new patent related to their chemotherpeutic delivery technology. The patent, entitled "Magnetically Responsive Nanoparticle Therapeutic Constructs and Methods of Making and Using" involves the bonding of a therapeutic molecule to a magnetic nanoparticle. This construct is introduced into the body then driven to the site within a focused magnetic field.
"Site-specific delivery of therapeutics has a host of advantages of traditional delivery methods," says Clinton Herring, President and CEO of SWR&D, Inc. "For example, in the treatment of cancer, this technology allows more chemotherapeutic to be delivered to the site while introducing less chemotherapeutic into the body. By doing so, no healthy tissue is affected and patients do not suffer the side effects associated with traditional chemotherapy."
Herring points out that, while the primary focus of this technology has been in the area of chemotherapy, it is being applied to other forms of therapy where site-specific delivery of therapeutics is desired. "This technology has caught the interest of other researchers who are exploring other applications. In fact, we are currently in the process of negotiating a non-exclusive license with a research organization in Oklahoma City."
Other patents related to this technology owned by SWR&D, Inc. include; Device for Moving Magnetic Nanoparticles Through Tissue and Delivery of Bioactive Substances to Target Cells.
####
For more information, please click here
Contacts:
Dennis Donaldson
Senior Vice President
SWR&D, Inc.
102 NE 20th
Lawton, OK 73507
V: 405.706.9687
Copyright © SWR&D, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||